Endocarditis following ocrelizumab in relapsing-remitting MS

Faissner, S; Schwake, C; Gotzmann, M; Mugge, A; Schmidt, S; Gold, R

Faissner, S (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020; 7 (3):

Abstract

Ocrelizumab is a monoclonal anti-CD20 antibody targeting B cells, which is authorized for relapsing-remitting MS (RRMS) and active primary progressive......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索